pharma · Analgesia · Postoperative Pain · HRTX
Heron Therapeutics
Heron Therapeutics is a pharma organization headquartered in Cary, USA. It trades on NYSE under ticker HRTX. Primary therapeutic focus areas include Analgesia, Postoperative Pain, Chemotherapy-induced Nausea and Vomiting
100 Regency Forest Dr, Cary, North Carolina 27518, US HQ
1983 Founded
188 Employees
Public company Type
HRTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Regency Forest Dr, Cary, North Carolina 27518, US
- Founded
- 1983
- Employees
- 188
- Programs
- 18
- Drugs
- 17
- Patents
- 46
GRANISETRON EXTENDED RELEASE INJECTION (GERSC)
Phase 2 · small molecule · Chemotherapy-induced Nausea and Vomiting
GRANISETRON EXTENDED RELEASE INJECTION (GERSC) for Chemotherapy-induced Nausea and Vomiting is a Phase 2 program (small_molecule) at Heron Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code UAB1950
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Heron Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Chemotherapy-induced Nausea and Vomiting
- Status
- terminated
- Trials
- 1